Our FAQ page offers essential details about Chirayu Super Speciality Hospital's services, treatments, and appointment booking. Find answers to common questions about our specialized medical care, diagnostic tests, and treatment options. This resource ensures a smooth, informed experience when accessing our comprehensive healthcare services.
The ANCA / PANCA Test detects antibodies associated with autoimmune diseases, helping in diagnosis and monitoring.
No specific preparation is usually required, but inform your healthcare provider about any medications you are taking.
Results are typically available within a few days, allowing for prompt medical decision-making and disease management.
Elevated levels suggest the presence of an autoimmune disease, such as vasculitis or granulomatosis with polyangiitis.
Yes, the test can help differentiate between types of autoimmune diseases based on the pattern and concentration of antibodies.
Elevated S.G.P.T levels may suggest liver damage or disease, such as hepatitis or fatty liver.
Yes, certain medications and supplements can influence S.G.P.T levels. It’s essential to inform your healthcare provider about all medications you are taking.
No, fasting is generally not required for this test unless specified by your healthcare provider.
The frequency of testing depends on your health condition and your healthcare provider’s recommendations.
Abnormal levels may indicate underlying liver issues. Further evaluation and treatment may be necessary based on your test results.
CRRT is a medical therapy used in intensive care units to manage patients with acute kidney injury (AKI) or severe kidney dysfunction. It involves the continuous removal of waste products and excess fluids from the blood.
CRRT is used when a patient’s kidneys are unable to adequately filter waste and excess fluids from the blood, leading to dangerous levels of toxins and fluid overload.
CRRT differs from hemodialysis in that it is slower and performed continuously over 24 hours or longer periods. Hemodialysis, on the other hand, is intermittent and typically lasts for a few hours.
Yes, CRRT can be used cautiously in patients with heart failure to manage fluid overload and electrolyte imbalances, with careful monitoring of hemodynamic status.
CRRT provides gentler and more gradual fluid and solute removal, making it suitable for hemodynamically unstable patients who cannot tolerate the rapid changes associated with conventional hemodialysis.